- About
- Advertise
- CureToday.com
- OncLive.com
- OncNursingNews.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2022 MJH Life Sciences™ and Cancer Network. All rights reserved.
Atish Choudhury, MD, PhD | Authors
Recent Updates in Prostate Cancer Care
April 08, 2022
Dr Choudhury shares recent updates from 2021 meetings including ASCO GU, AUA, and ESMO.
Trends in Prostate Cancer Care
April 04, 2022
Prostate cancer experts share exciting changes to the prostate cancer treatment landscape and how we are now better equipped to take care of patients with prostate cancer.
Sequencing in mCSPC
March 23, 2022
A prostate cancer expert shares rationale for his preferences and choices while sequencing therapies in prostate cancer.
Duration of Treatment for Patients with mCSPC
March 16, 2022
Dr Bobby Liaw talks about relationship between treatment duration, dosing and efficacy.
Safety Considerations in mCSPC and Selection of Androgen Receptor Pathway Inhibitors
March 10, 2022
Dr. Atish Choudhury discusses safety features to keep in mind when choosing androgen receptor pathway inhibitors.
Long-Term Data with Androgen Receptor Pathway Inhibitors
March 10, 2022
A prostate cancer expert shares long-term data with androgen receptor pathway inhibitors in mCSPC.
Treatment Options and Considerations in mCSPC
March 09, 2022
Dr. Choudhury discusses treatment considerations and treatment options for mCSPC.
Diagnosis and Management of mCSPC
December 22, 2021
Dr. Atish Choudhury provides an overview of advances and changes in management of patients with metastatic castration sensitive prostate cancer (mCSPC) in the last decade.